Tidal Investments LLC grew its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 38.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,357 shares of the insurance provider's stock after purchasing an additional 6,755 shares during the period. Tidal Investments LLC's holdings in Humana were worth $7,715,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in HUM. PDT Partners LLC raised its holdings in shares of Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock worth $1,286,000 after buying an additional 2,660 shares during the last quarter. Ontario Teachers Pension Plan Board raised its stake in Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider's stock worth $371,705,000 after acquiring an additional 71,910 shares during the last quarter. Swedbank AB lifted its position in Humana by 3.0% during the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider's stock worth $33,567,000 after acquiring an additional 3,085 shares during the period. Heritage Oak Wealth Advisors LLC purchased a new stake in Humana during the 2nd quarter valued at about $3,456,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Humana by 3.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 899,191 shares of the insurance provider's stock valued at $284,810,000 after purchasing an additional 26,056 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.
Analyst Ratings Changes
A number of brokerages recently commented on HUM. Cantor Fitzgerald reiterated a "neutral" rating and issued a $395.00 target price on shares of Humana in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Humana from $349.00 to $250.00 and set a "hold" rating on the stock in a report on Thursday, October 3rd. Bank of America raised shares of Humana from an "underperform" rating to a "neutral" rating and raised their target price for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Barclays upped their price target on shares of Humana from $250.00 to $253.00 and gave the company an "equal weight" rating in a report on Thursday, October 31st. Finally, Leerink Partners lowered Humana from an "outperform" rating to a "market perform" rating and reduced their price objective for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Humana has an average rating of "Hold" and a consensus target price of $304.15.
View Our Latest Analysis on Humana
Humana Price Performance
NYSE:HUM traded down $0.54 during trading hours on Friday, hitting $272.24. 1,038,247 shares of the stock were exchanged, compared to its average volume of 1,840,003. The firm's fifty day moving average price is $273.45 and its 200 day moving average price is $325.22. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $486.00. The company has a market cap of $32.78 billion, a P/E ratio of 24.16, a P/E/G ratio of 2.15 and a beta of 0.53. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.
Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analysts' expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, equities research analysts anticipate that Humana Inc. will post 16.14 EPS for the current fiscal year.
Humana Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.30%. Humana's payout ratio is 31.36%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
